Specify a stock or a cryptocurrency in the search bar to get a summary
Novogene Co. Ltd.
688315Novogene Co., Ltd. provides genomic services and solutions worldwide. The company offers genomic solutions, such as human genome sequencing, gene regulation, single cell sequencing, animal and plant solutions, and microbial genome sequencing; and cancer genomic profiling, whole exome sequencing, and FFPE RNA sequencing, as well as clinical-grade whole exome sequencing services. It also provides NovoFocus CR, a gene coverage for hereditary cancer screening; and NovoNeoantigen, a bioinformatics pipeline for the identification of cancer neoantigens with whole exome sequencing and whole transcriptome sequencing data from paired tumor-normal samples. The company was founded in 2011 and is headquartered in Beijing, China. Address: Building 301, Beijing, China
Analytics
WallStreet Target Price
135.46 CNYP/E ratio
30.0435Dividend Yield
0.36 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 688315
Dividend Analytics 688315
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
12 %Dividend History 688315
Stock Valuation 688315
Financials 688315
Results | 2019 | Dynamics |